PET and clinical studies Data analysis studies Experimental studies
The serotonergic system in patients with cognitive and
emotional disturbances
Responsible: Steen
Hasselbalch
Molecular imaging of the brain’s 5-HT4 serotonin receptor and amyloid load
in healthy and Alzheimer patients and in patients at risk for depression
Responsible: Karine Madsen, Steen Hasselbalch
The serotonergic system in affective disorders
Responsible: Vibe Frøkjær
The
serotonergic system in early Alzheimer’s disease
Responsible: Lisbeth Marner, Steen Hasselbalch
Characterization of the serotonergic transmittersystem
and brain morphology in young adult MDMA abusers
Responsible: David Erritzøe
The serotonergic transmittersystem in obesity
Responsible: Mette Haahr
Neuroinformatics
Responsible: Finn Aarup Nielsen
Automatic
definition of volumes of interest (VOI's)
Responsible: Claus Svarer
BDNF and 5-HT2A receptor interaction: Role in depression
and antidepressant treatment
Responsible: Anders Bue Klein
5-HT2A receptor ineraction with other receptor systems and its involvement in synaptic plasticity
Responsible:
Martin Santini
Relation between amyloid beta depositions and structure,
receptor content and cognition in minipigs
Responsible: Birgitte Rahbek
Kornum
The 5-HT2A receptor in Alzheimer animal models
Responsible: Susana Aznar
Characterization of the alpha-7 nicotinic receptor in cognition and schizophrenia
Responsible: Morten Skøtt Thomsen
Characterization of the 5-HT2A radiolabelled agonists and its effect on 5-HT2A receptors
Responsible: Mikael Palner
Validation of 5-HT2A agonist as new PET ligands in minipigs
Responsible: Anders Ettrup
Relation between serotonergic innervation and predisposition to depression
Responsible: Susana Aznar
Cerebral blood flow autoregulation in renal dysfunction
Responsible: Sigurd Sigurdsson and Olaf B. Paulson